Literature DB >> 28667425

Effectiveness of catheter directed thrombolysis and stent implantation on iliofemoral vein thrombosis caused by iliac vein compression.

Zhi-Bing Ming1, Wen-Dong Li2, Rui-Fan Yuan1, Xiao-Qiang Li2, Wen-Bin Ding3.   

Abstract

The purpose of this study was to objectively assess the morbidity of post-thrombotic syndrome (PTS) in iliofemoral vein thrombosis treated with catheter-directed thrombolysis (CDT) and stenting under the protection of inferior vena cava (IVC) filter. All patients with an unprovoked episode of iliofemoral vein thrombosis combined with iliac vein compression syndrome (IVCS) during January 2011 and January 2015 were enrolled. Clinical records of all patients were evaluated. Firstly, cox regression was performed to find out the factors impacted the incidence of PTS. Then, Kaplan Meier analysis was conducted to verify the roles of these factors in PTS. A total of 247 patients who underwent CDT and IVC filter insertion for iliofemoral vein thrombosis and were found stenosis in the iliac vein after CDT were included in this study. Among them, 74 patients suffered PTS diagnosed via Villalta scale. Comparison with patients without stent implantation and filter withdrawal, patients with stent implantation and filter withdrawal had a less risk of PTS, but patients with a lesion in the left or bilateral proximal deep vein had a more risk of PTS. Cox regression found that stent implantation was a preventive measure to prevent PTS (OR 0.541, 95% CI 0.334-0.876, p = 0.012). The Kaplan-Meier curve found that patients with stent implantation had a less ratio of PTS occurrence (P = 0.008). In patients with iliofemoral vein thrombosis and IVCS, stent implantation to solve the residual obstruction after CDT might play an important role in preventing PTS.

Entities:  

Keywords:  Catheter-directed thrombolysis; Deep vein thrombosis; Iliac vein compression; Inferior vena cava filter; Stent implantation

Mesh:

Year:  2017        PMID: 28667425     DOI: 10.1007/s11239-017-1515-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  44 in total

Review 1.  Interventional approaches in VTE treatment (vena cava filters, catheter-guided thrombolysis, thrombosuction).

Authors:  Davide Imberti; Cinzia Maraldi; Massimo Gallerani
Journal:  Semin Respir Crit Care Med       Date:  2012-05-30       Impact factor: 3.119

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

3.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

Authors:  H Decousus; A Leizorovicz; F Parent; Y Page; B Tardy; P Girard; S Laporte; R Faivre; B Charbonnier; F G Barral; Y Huet; G Simonneau
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

4.  Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.

Authors: 
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

5.  Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis.

Authors:  S R Kahn; C Kearon; J A Julian; B Mackinnon; M J Kovacs; P Wells; M A Crowther; D R Anderson; P Van Nguyen; C Demers; S Solymoss; J Kassis; W Geerts; M Rodger; J Hambleton; J S Ginsberg
Journal:  J Thromb Haemost       Date:  2005-02-23       Impact factor: 5.824

Review 6.  Pulmonary embolism and deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Henri Bounameaux
Journal:  Lancet       Date:  2012-04-10       Impact factor: 79.321

7.  Determinants of chronic venous disease after acute deep venous thrombosis.

Authors:  M H Meissner; M T Caps; B K Zierler; N Polissar; R O Bergelin; R A Manzo; D E Strandness
Journal:  J Vasc Surg       Date:  1998-11       Impact factor: 4.268

8.  Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic syndrome: a prospective study.

Authors:  M Monreal; A Martorell; J M Callejas; R Valls; J F Llamazares; E Lafoz; A Arias
Journal:  J Intern Med       Date:  1993-03       Impact factor: 8.989

9.  Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.

Authors:  José A González-Fajardo; Miguel Martin-Pedrosa; Javier Castrodeza; Sonia Tamames; Carlos Vaquero-Puerta
Journal:  J Vasc Surg       Date:  2008-07-18       Impact factor: 4.268

10.  Catheter-directed thrombolysis with a continuous infusion of low-dose urokinase for non-acute deep venous thrombosis of the lower extremity.

Authors:  Binbin Gao; Jingyong Zhang; Xuejun Wu; Zonglin Han; Hua Zhou; Dianning Dong; Xing Jin
Journal:  Korean J Radiol       Date:  2011-01-03       Impact factor: 3.500

View more
  4 in total

1.  Efficacy Analysis of Endovascular Therapy for Nonthrombotic Iliac Vein Compression Syndrome Combined with Chronic Venous Insufficiency.

Authors:  Renda Zhu; Xiaodong Jin; Jiayi Shen
Journal:  Comput Math Methods Med       Date:  2022-07-26       Impact factor: 2.809

Review 2.  [Antithrombotic therapy after iliac vein stenting].

Authors:  Wen Zhong; Yan Lou; Chenyang Qiu; Donglin Li; Hongkun Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

3.  MiR-9 promotes angiogenesis of endothelial progenitor cell to facilitate thrombi recanalization via targeting TRPM7 through PI3K/Akt/autophagy pathway.

Authors:  Dong-Ming Zhou; Li-Li Sun; Jian Zhu; Bing Chen; Xiao-Qiang Li; Wen-Dong Li
Journal:  J Cell Mol Med       Date:  2020-03-09       Impact factor: 5.310

4.  Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review.

Authors:  Pascale Notten; Hugo Ten Cate; Arina J Ten Cate-Hoek
Journal:  J Thromb Haemost       Date:  2021-01-05       Impact factor: 5.824

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.